Search Results

You searched for : Zydusnews  

	Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).... Jun 24
	Zydus and Bayer announce continuity of their successful Joint Venture Bayer Zydus Pharma has been a successful partnership combining Bayer’s scientific expertise and commercialization of novel products backed by Cadila Healthcare’s strong India ... Jun 22
	Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablet Brivaracetam is used to treat partial-onset of seizures (epilepsy)... Jun 14
	Zydus announces Phase I trials of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor Zydus, today announced that it has received permission to initiate the Phase 1 clinical trial of ZYIL1, a novel oral small molecule NLRP3 inhibitor candidate.... Dec 07
	Zydus announces IND filing of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor NLRP3 inflammasome inhibitor can selectively modulate the inflammatory responses caused by the ‘Cytokine Storm’ in Acute Respiratory Distress Syndrome... Nov 03
	Zydus Cadila receives final approval from USFDA for Albuterol Tablets Albuterol is a bronchodilator and it helps open up the airways in your lungs to make it easier to breathe. ... Oct 23
	Zydus Cadila receives Final Approval from USFDA for Solifenacin Succinate Tablets Zydus Cadila has received final approval from the USFDA to market Solifenacin Succinate Tablets, in the strengths of 5 mg and 10 mg... Oct 21
	Zydus Healthcare launches highly affordable Dapagliflozin tablets in India for the treatment of Type 2 diabetes Zydus Healthcare Limited announced that it is launching the anti-diabetic Dapagliflozin tablets in India upon its patent expiry under the brand name ‘Dapaglyn’... Oct 05
	Zydus Cadila receives tentative approval from USFDA for Palbociclib Capsules Zydus Cadila has received tentative approval from the USFDA to market Palbociclib Capsules, an anti-cancer medicine... Sep 24
9 Matching result(s) found!

Trending Now
	Dark Web Health Data: Why Medical Records MatterOctober 27, 2026
	Can Conversational AI Improve Patient Follow-Up After Discharge?October 27, 2026
	UAE fast-tracking advanced diagnostics as global market heads for US$152 billionOctober 26, 2026
	How Digital Check-In Can Support More Accessible Patient JourneysOctober 26, 2026
	The Role of Consent Communication in Digital Healthcare ServicesOctober 26, 2026
	How Data Analytics Is Transforming Hospital Decision-MakingOctober 26, 2026
	Hospital Intelligence: The Next Big Leadership Shift in India October 26, 2026
	What Patients Should Expect From a Well-Designed Health Checkup ProgrammeOctober 23, 2026
	Building Stronger Community-Based Screening ProgrammesOctober 23, 2026
	Gulf Medical University Ranks 1st for International Student Ratio in QS Arab Region Rankings 2027October 22, 2026
	Arthritis Is Not Just an Elderly Person's Disease: Why Younger Adults Are Also Developing Joint ProblemsOctober 22, 2026
	Krishna Automotive strengthens its operations in Hyderabad. Enhances customer offering with BMW Service Workshop and BMW Premium Selection.October 22, 2026
	CTR-JK Tyre FMSCI Indian National Car Racing Championship 2026 set for season opener in CoimbatoreOctober 22, 2026
	The Anonymous Indian Charitable Trust (TAICT) Wins Sustainable Organization Award 2026October 22, 2026
	Vinod Intelligent Cookware Targets Delhi’s Premium Cookware Market with Freya Brand ActivationOctober 22, 2026
	Apollo Hospitals and Avadi Police Commissionerate Organise Health Camp for Police Personnel and Their Families Under ‘Kaval Kudumbam’ SchemeOctober 22, 2026
	TAMPOS Midterm Conference 2026 Brings Together 150 Oncologists to Advance Cancer Care Across Tamil NaduOctober 22, 2026
	Shades of Pink: Apollo Athenaa Women's Cancer Centres puts the spotlight on breast health awarenessOctober 22, 2026
	How Health Systems Can Reduce Missed Follow-UpsOctober 21, 2026
	What Good Care Coordination Looks Like Across Multiple ProvidersOctober 21, 2026